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Abstract
Background: The need for rapid and efficient microbial cell factory design and construction are possible through
the enabling technology, metabolic engineering, which is now being facilitated by systems biology approaches.
Metabolic engineering is often complimented by directed evolution, where selective pressure is applied to a
partially genetically engineered strain to confer a desirable phenotype. The exact genetic modification or resulting
genotype that leads to the improved phenotype is often not identified or understood to enable further metabolic
engineering.
Results: In this work we performed whole genome high-throughput sequencing and annotation can be used to
identify single nucleotide polymorphisms (SNPs) between Saccharomyces cerevisiae strains S288c and CEN.PK113-7D.
The yeast strain S288c was the first eukaryote sequenced, serving as the reference genome for the Saccharomyces
Genome Database, while CEN.PK113-7D is a preferred laboratory strain for industrial biotechnology research. A total
of 13,787 high-quality SNPs were detected between both strains (reference strain: S288c). Considering only
metabolic genes (782 of 5,596 annotated genes), a total of 219 metabolism specific SNPs are distributed across 158
metabolic genes, with 85 of the SNPs being nonsynonymous (e.g., encoding amino acid modifications). Amongst
metabolic SNPs detected, there was pathway enrichment in the galactose uptake pathway (GAL1, GAL10) and
ergosterol biosynthetic pathway (ERG8, ERG9). Physiological characterization confirmed a strong deficiency in
galactose uptake and metabolism in S288c compared to CEN.PK113-7D, and similarly, ergosterol content in CEN.
PK113-7D was significantly higher in both glucose and galactose supplemented cultivations compared to S288c.
Furthermore, DNA microarray profiling of S288c and CEN.PK113-7D in both glucose and galactose batch cultures
did not provide a clear hypothesis for major phenotypes observed, suggesting that genotype to phenotype
correlations are manifested post-transcriptionally or post-translationally either through protein concentration and/or
function.
Conclusions: With an intensifying need for microbial cell factories that produce a wide array of target compounds,
whole genome high-throughput sequencing and annotation for SNP detection can aid in better reducing and
defining the metabolic landscape. This work demonstrates direct correlations between genotype and phenotype
that provides clear and high-probability of success metabolic engineering targets. The genome sequence,
annotation, and a SNP viewer of CEN.PK113-7D are deposited at http://www.sysbio.se/cenpk.
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Metabolic engineering is the enabling technology for
identification of targeted genetic modifications such as
gene deletion, over-expression, or modulation. The
genetic engineering implemented in a host microbial
cell factory ideally will lead to re-direction of fluxes to
enhance production or robustness of a given product or
organism, respectively [1-5]. Metabolic engineering
through systems biology has been complimented, and its
application expanded in both scope and success. Sys-
tems biology is a multi-disciplinary approach to quanti-
tative collection, analysis, and integration of whole
genome scale data sets enabling construction of biologi-
cally relevant and often predictive mathematical models
[6-8]. Genome sequencing of industrially relevant organ-
isms, including S. cerevisiae strain S288c, the first eukar-
yote genome sequence reported, provided a framework
for gene annotation through functional genomics. More
relevant to metabolic engineering, an annotated genome
sequence was a prerequisite for genome-scale metabolic
network reconstructions [9,10]. Such reconstructions
offer a biochemical model describing the formation and
depletion of each metabolite that by providing mass-bal-
ance boundary conditions makes possible constraint
based simulations of how the metabolic network oper-
ates at different conditions.I ns i m p l e rt e r m s ,u s i n g
basic stoichiometry these models can be used to predict
the relationships between gene functions in the cellular
metabolic network. With nearly 14 years elapsing since
the S. cerevisiae strain S288c genome sequence was
made available, and more than 1,000 laboratories parti-
cipating in functional genomics efforts, there are still
968 and 811 open reading frames (ORFs) classified as
uncharacterized and dubious, respectively, according to
the Saccharomyces Genome Database (SGD) [10,11].
Furthermore, since 2003 there have been published five
major S. cerevisiae genome-scale metabolic network
reconstructions, with the most recent models encom-
passing between 13-14% genome coverage [12,13]. The
opportunity to further extend genotype to phenotype
annotation is abundant.
Industrial biotechnology is dominated by efforts to
confer a desirable phenotype onto strains using different
methods of directed evolution and random mutagenesis,
requiring screening and selection. This approach, while
providing little to no mechanistic understanding of
which specific genetic perturbations lead to improved
strains so they could be further exploited, has proven to
be commercially successful as illustrated by the more
than 1,000 fold improvement in penicillin titer by Peni-
cillium chrysogenum [14]. As industrial biotechnology
applications expand, and the desire to custom-engineer
microbial cell factories with novel architecture for native
and heterologous metabolic pathways increases, the
necessity on a genome-wide level to understand direct
genotype to phenotype relationships has rapidly
increased. Within the same time period of approxi-
mately the last 10 years, the technologies and costs asso-
ciated with whole genome sequencing have advanced
and decreased, respectively. There are several excellent
reviews of genome sequencing technologies, and their
applications to functional genomics, strain engineering,
and other investigatory biology efforts [5,15-18]. Prior
work, specifically focused on characterizing genome-
wide analysis of nucleotide polymorphisms in S. cerevi-
siae utilized 25mers oligonucleotide microarrays
(Affymetrix yeast tiling arrays) providing random and
redundant coverage of the S. cerevisiae genome [19].
This analysis included single nucleotide polymorphism
(SNP) identification between S288c and the commonly
used laboratory strain S. cerevisiae CEN.PK, where a
total of 13,914 SNPs were identified. However, this
approach is unable to identify the exact nucleotide sub-
stitution, and consequently whether the transcribed SNP
results in an amino acid substitution, presumably
required to confer a change in enzyme and/or protein
function. More recently a collaborative project, the Sac-
charomyces Genome Resequencing Project (SGRP)
between the Sanger Institute and Institute of Genetics,
University of Nottingham, completed the ABI sequen-
cing of haploids of 37 S. cerevisiae strains to a coverage
of 1-3X. Furthermore, Illumina-Solexa genome sequen-
cing of four of the 37 S. cerevisiae strains, one of which
included S288c, was completed [20]. This sequencing
effort was focused on exploration of genomic variation
in the context of evolution, thereby using multiple
strains from different Saccharomyces species. It is a
demonstration of a recent genome sequencing technol-
ogy, referred to as Illumina-Solexa sequencing, com-
pared to larger read methods such as Sanger or 454
sequencing. Illumina-Solexa sequencing is an ultra-high-
throughput technology that performs sequencing-by-
synthesis of random arrays of clonal DNA colonies
attached to the surface of a flow-cell. The approach
used in this study generates short, 35 base pair (bp)
reads (currently, the technology limitations are 150 bp
or 2 × 150 bp paired-reads), that must then be aligned
to and assembled using a reference genome [21-23].
In this work we propose that high-throughput genome
sequencing and annotation, integrated with a genome
browser and SNP viewer of S. cerevisiae may serve as a
commonplace tool, complementary to transcriptomics
and physiological characterization, to extract direct gen-
otype to phenotype information. Firstly, whole genome
Illumina-Solexa sequencing of each strain was com-
pleted and then annotation was performed. To access
annotated genome sequences and detected SNPs of
CEN.PK113-7D, a genome browser and SNP viewer
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were identified, characterized, and amino acid level ana-
lysis performed. In order to directly link genotype to
phenotype cellular behavior was characterized in well-
controlled batch fermentations on glucose and galactose,
complimented with transcriptome analysis. More specifi-
cally, we demonstrate that S288c, the strain utilized for
the publically available S. cerevisiae genome sequence,
exhibits atypical S. cerevisiae behavior related to central
carbon metabolism as compared to CEN.PK113-7D, a
common laboratory strain for industrial biotechnology
applications [24].
There were clear correlations between physiology and
metabolic pathway enrichment of nonsynonymous SNPs
observed, suggesting that sequencing and the annotated
genome may assist in reducing the genetic target space
for metabolic engineering applications. The analysis pre-
sented here serves as a foundation for comparative
metabolic engineering SNP analysis, wherein the future
reference strains may be compared to their metabolically
engineered derivatives that use directed evolution in
order to answer the age-old question: what changed in
our strain that makes it a preferred microbial cell
factory?
Results
Genome Sequencing and Annotation
The genome sequencing of S. cerevisiae strain CEN.
PK113-7D and genome re-sequencing of strain S288c
were accomplished using the Illumina/Solexa technol-
ogy. According to the manufacturer’s recommendations
(Illumina), raw sequence reads of strain CEN.PK113-7D
and strain S288c were accumulated to approximately
18× and 15× depth coverage, respectively. Reads were
mapped on the S288c as reference genome using MAQ
software http://maq.sourceforge.net. Based on genome
sequence analysis and annotation (See Methods), the
12.1 Mb genome was predicted to contain a total of
5,596 genes encoding proteins. The genome was pre-
dicted to comprise 16 chromosomes by pair-wise com-
parison against the 16 different chromosomes of the
public reference strain S288c from the Saccharomyces
Genome Database (SGD). Interestingly, we found that
genome characteristics of strain CEN.PK113-7D are very
similar to S288c for genome parameters that include
total size, chromosome length, GC content, and the
number of predicted genes. Table 1 summarizes Illu-
mina genome sequencing and annotation results.
Genome Browser and SNP Viewer
To visualize genome sequences, annotated genes, and
detected SNPs of S. cerevisiae CEN.PK 113-7D, a PHP-
MySQL-based genome browser and SNP viewer were
developed and deposited on the web-site (See http://
www.sysbio.se/cenpk). The basic genome browser func-
tionality, as seen in Figure 1, can provide genome anno-
tation views with an overhead bar providing a visual
indication of chromosome position. It is possible to
navigate by dragging the display left or right creating a
smooth panning effect. Alternatively, one can navigate
directly to a region (e.g., gene name) of interest by pro-
viding the region coordinates or typing a feature name
into the quick search box. The browser can display
basic genomic features of interest (e.g., geneID, gene
name, gene function, location, gene ontology process,
and exon/intron structures). Similarly, for the SNP
viewer one can visualize nucleotide and amino acid
polymorphism data between S. cerevisiae strains. The
w h o l eg e n ec o n t a i n i n gaS N P( s )c a nb ed i s p l a y e db y
dragging left or right button (which creates a smooth
panning effect), and also highlight the mutated position
(e.g., nonsynonymous SNP (s), silent SNP (s)) between
S. cerevisiae strains.
SNPs identification in metabolism
Based on whole genome sequencing, data that includes
the number of reads, average coverage relative to the
SGD reference genome, total number of non-ambiguous
SNPs, and total number of filtered SNPs and detected
SNPs error are presented in Table 2. Not surprisingly,
S288c had relatively few SNPs compared to CEN.
PK113-7D given that the reference genome from SGD is
based on S288c version 12.0 [10,11]. Furthermore, the
13,787 filtered SNPs identified using the MAQ software
is consistent with the previously estimated 13,914 SNPs
for CEN.PK113-7D based upon DNA hybridization to
25mers olignonucleotide microarrays [19]. Table 2 also
presents the results for metabolic SNP detection, where
a total of 782 metabolic genes as defined by SGD were
used to query for SNPs in both the S288c and CEN.
PK113-7D genome sequences. A total of 36 metabolic
SNPc of S288c, 3 of which are nonsynonymous, were
identified across 14 independent metabolic genes (3 non-
synonymous SNPs distributed across 3 metabolic genes).
Table 1 Illumina/Solexa genome sequencing and
annotation results
Sequencing Parameter S288c CEN.PK113-7D
No. of Reads 5,301,907 6,603,200
No. of Aligned Reads 5,176,155 6,216,656
Total Bases
A (bp) 181,165,425 217,582,960
Calculated Average Coverage 15x 18×
Genome Percent Reference
Coverage (%)
99.9 99.4
No. of chromosomes 16 16
%GC content 38.3 38.3
Notes: Base pairs (bp). (A) Each read is 35 base pairs in length.
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were detected in CEN.PK113-7D and distributed across
158 unique metabolic genes, 85 of which contained a
total 219 nonsynonymous SNPs.
In an effort to characterize the nonsynonymous meta-
bolic SNPs identified in CEN.PK113-7D with biological
significance, Gene Ontology (GO) process categorization
was performed and presented in Figure 2 ranked
according to statistical significance (p < 0.01). The most
significant categories include carboxylic acid, organic
acid, and carbohydrate metabolism, followed by nitro-
gen, amino acid, lipid, aromatic compound, and glyco-
protein metabolism. Additional file 1 Figure S1 presents
the GO function and component categorization, and as
expected the highest significant concentration of nonsy-
nonymous SNPs (p < 0.01) distributed across a specific
enzyme class is for transferases. Notably, the back-
ground genes used for GO enrichment analysis were the
complete gene set available in SGD (verified, unverified,
and dubious). GO enrichment analysis uses a hypergeo-
metric distribution with Multiple Hypothesis Correct to
calculate p-values and correct for multiple sampling.
A graphical representation of all silent and nonsynon-
ymous SNPs mapped to their specific metabolic path-
ways is presented in Additional file 1 Figure S2. Figure 3
highlights two metabolic pathways, galactose uptake and
ergosterol synthesis, where an enrichment of nonsynon-
ymous and silent SNPs was observed. Specifically,
GAL1, GAL10, ERG8,a n dERG9 contained nonsynon-
ymous SNPs, while GAL7, ERG20 and HMG1 contained
silent SNPs. The specific SNPs are identified as well the
resulting amino acid substitutions.
In addition to identifying SNP enriched metabolic
pathways in CEN.PK113-7D, an analysis intended to
determine the prevalence of the SNP across the top 10
homologous sequences resulting from a multi-alignment
ǀĂŝůĂďůĞdƌĂĐŬƐ
ůŝĐŬͲхdŽǀŝĞǁ

bp
Genes
650000                                                                                               750000

Figure 1 Screenshot of Genome Browser and SNP viewer displaying chromosome 13 of S. cerevisiae CEN.PK113-7D. The navigation
panel (A) includes an overview of the genome, gene ID, gene name, gene function and the current location in the chromosome, together with
exon and intron structure, and a text box for quick searching. Below this is a frameshowing the SNP viewer. (B) SNP information section for
displaying nucleotide and amino acid polymorphism data between yeast S. cerevisiae strains.
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results, the parameters CEN.PK Match Frequency, Domi-
nant AA Frequency, S288c Match Frequency, and Conser-
vation Distance were defined and calculated (See
Additional file 1 Figure S3). The Conservation Distance,
bound between -1 and 1, is a measure of whether the
SNP identified in CEN.PK113-7D is more prevalent
amongst homologous Pfam sequences (maximum Con-
servation Distance = -1), or if S288c (reference SGD
sequence) is more prevalent (maximum Conservation
Distance = +1). Additional file 1 Figure S4 presents the
Conservation Distance across nonsynonymous SNPs
identified, with the average value of 0.03 ± 0.40 (n=219),
indicating that there is virtually no bias between S288c or
CEN.PK113-7D as compared to their homologues.
Extending this approach further, each amino acid poly-
morphism was characterized across a multi-alignment
Pfam homologue search, and categorized according to
standard amino acid properties (See Additional file 1
Figure S3). For example, Figure 4 presents SNPs identi-
fied in ERG8 at nucleotide positions 75 and 192. The
resulting amino acid partially encoded by position 192
was 75% polar, 25% non-polar, 25% hydrophobic, and
75% hydroxylic looking across the top 10 Pfam homolo-
gous sequences. Lastly, and of most relevance to under-
standing the amino acid functional changes resulting
from a SNP, the same categorization is presented for the
S288c v. CEN.PK113-7D sequence. For example, the SNP
at position 192 of ERG8 resulted in changing the encoded
amino acid from non-polar (S288c) to polar (CEN.
PK113-7D), and from hydrophobic (S288c) to hydroxylic
(CEN.PK113-7D). This approach is extended to all the
ERG8 nonsynonymous SNPs as an example of extending
nucleotide level changes to amino acid functional
changes (See Additional file 1 Figure S5 for additional
ERG8 nonsynonymous SNPs). Furthermore, Additional
file 1 Figure S6 highlights functional changes for all
metabolic nonsynonymous SNPs identified.
Physiological Characterization
The S. cerevisiae strains S288c and CEN.PK113-7D were
physiologically characterized in both batch glucose and
galactose supplemented fermentations. On glucose,
CEN.PK113-7D exhibited a 32% higher specific growth
rate than S288c, correlating with the 33% higher specific
glucose consumption rate (See Table 3). The CEN.
PK113-7D extracellular metabolic specific productivity
rates were 32.6%, 392%, and 17.9% higher for ethanol,
acetate, and glycerol production compared to S288c,
respectively, while the specific oxygen consumption
rates were nearly equivalent (1.98 O2-mmol g-DCW
-1 h
-1
for CEN.PK113-7D v. 1.95 mmol-O2 g-DCW
-1 h
-1 for
S288c). Following complete glucose fermentation, as
indicated by the peak carbon dioxide evolution rate
(CER), both strains underwent a diauxic shift, clearly
identified by the transition of the respiratory quotient
(RQ) from > 1 to < 1, and ethanol accumulated during
glucose fermentation (11.1 g L
-1 for CEN.PK113-7D v.
11.3 g L
-1 for S288c) was respiro-fermented. The ethanol
respiro-fermentation (ERF) phase (Figure 5) was clearly
distinguishable in the CEN.PK113-7D compared to
S288c, where both CER and oxygen uptake rates (OUR)
Table 2 Genome sequencing and metabolic SNP detection
Sequencing Parameter S288c CEN.PK113-7D
MAQ Software Determination
No. of Reads 5,301,907 6,603,200
Total No. of SNPs 3,032 27,868
Total No. of Non-Ambiguous SNPs 1,013 24,663
Total No. of Filtered SNPs
A,B 311 13,787
Metabolism Focused Detection
Total No. of Metabolic Genes Considered
C 782 782
Total No. of Metabolic Bases (bp) 1.16M 1.16M
No. of Aligned Reads 477,565 623,400
Total Gap Size (bp) 00
Metabolic Genome Percent Reference Coverage (%) 99.7 99.4
Total No. of Metabolic SNPs detected 36 939
Total No. Nonsynonymous Metabolic SNPs Detected 3 219
Percent of SNPs Detected Nonsynonymous (%) 8.3 23.3
Total No. of Metabolic Genes Containing SNP 14 158
Total No. of Metabolic Genes with Nonsynonymous SNP 38 5
Notes: Base pairs (bp). (A) Filtered SNPs determined based on cut-off criteria within the Mapping and Assembling with Quality (MAQ) software environment. (B)
Detected SNPs with estimated error < 0.003% (C) The total number of genes classified as metabolic was based on the Saccharomyces Genome Database, Strain
S288c, version 12.0. The “S288c” designation in Table 2 refers to the resequencing of S. cerevisiae S288c using Illumnia/Solexa sequencing technology.
Otero et al. BMC Genomics 2010, 11:723
http://www.biomedcentral.com/1471-2164/11/723
Page 5 of 17linearly increased, corresponding with the increase in
biomass (3.7 to 12.0 g-DCW L
-1). On the contrary, dur-
ing the ERF phase for S288c there was a growth defi-
ciency, clearly indicated by non-linear and significantly
reduced CER and OUR rates, corresponding with a much
lower increase in biomass (2.1 to 6.9 g-DCW L
-1). The
significantly decreased ERF phase in S288c compared to
CEN.PK113-7D is also evident from the total time
required to exhaust the ethanol (50 v. 33 h, respectively).
A similar characterization was performed using batch
galactose supplemented fermentations. CEN.PK113-7D
demonstrated a slight lag-phase compared to glucose fer-
mentation; however, sustained a galactose specific growth
rate of 0.27 h
-1 and galactose uptake rate of 24.3 C-mmol
g-DCW
-1 h
-1, representing a 34% and 77% reduction,
respectively, compared to glucose (See Table 3). All extra-
cellular metabolic specific productivity rates were
significantly decreased (ethanol, acetate, and glycerol were
93%, 6.8%, and 88% reduced compared to glucose, respec-
tively), with the exception of OUR, which was 47% higher
on galactose compared to glucose, leading to an effectively
lower RQ of 1.5 compared to 11.9 during glucose cultiva-
tion. Furthermore, given the significantly lower RQ during
the exponential phase of galactose fermentation, relatively
little ethanol was produced (2.7 g L
-1), resulting in a short
ERF phase (< 5h) (See Figure 5). Similarly, S288c was culti-
vated on galactose; however, a significant deficiency in the
strain’s ability to metabolize this carbon source was
observed. A total of 25 h post-inoculation elapsed with no
increase in biomass as compared to CEN.PK113-7D where
after 6 h post-inoculation two cell doublings were observed.
At 25 h post-inoculation a glucose bolus of 10 g L
-1 was
added to promote growth, and rapidly, glucose fermenta-
tion, a diauxic shift, and ethanol respiro-fermentation were
GO PROCESS, Nonsynonymous SNP Characterization 
 
Figure 2 Gene Ontology (GO) process terms for the nonsynonymous SNPs identified in CEN.PK113-7D compared to S288c. The x-axis in
log-scale displays both the significance of each category (p < 0.01, symbol: solid black), and the number of genes from the total of 85
containing nonsynonymous SNPs (symbol: solid white). GO process characterization performed using the Saccharomyces Genome Database
(SGD).
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Figure 3 Enriched SNP in galactose uptake pathway and ergosterol synthesis pathway. Two pathways with a significant number of SNPs,
both silent (blue) and nonsynonymous (red) are included: galactose uptake pathway and ergosterol synthesis pathway. The significance of each
pathway (p < 0.01). Both standard single letter codes for nucleotides and amino acids are utilized.
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Page 7 of 17observed (See Figure 5). Both co-consumption of galactose
and ethanol, and a galactose only respiro-fermentative
(GaRF) growth phase were observed. During co-consump-
t i o nt h es p e c i f i cg r o w t hr a t ew a s0 . 1 4h
-1, while on galactose
only the specific growth rate was 0.02 h
-1. Similarly, the
extracellular specific metabolite productivity rates were
nearly zero when only galactose consumption was consid-
ered (See Table 3). Ethanol was consumed by 82 h post-
inoculation, and in the period from 82 h to 128 h, only
galactose consumption was observed, and biomass
increased from 7.9 g-DCWL L
-1 to 20.9 g-DCW L
-1,r e p r e -
senting a doubling time of 35 h compared to 2.6 h for CEN.
PK113-7D.
For each cultivation condition and strain, ergosterol mea-
surements were performed and presented in Figure 6. At
the same time of transcriptome sampling, which occurred
during mid-exponential phase of glucose fermentation (18-
20 h), a total ergosterol of 7.6 ± 0.5 mg g-DCW
-1 and 3.3 ±
0.5 mg g-DCW
-1 for CEN.PK113-7D and S288c, respec-
tively, was measured. Subsequently, the diauxic shift and
ERF phase was characterized by two ergosterol samples
during early and mid-ERF phase, and followed by a final
(stationary) sample post-ethanol exhaustion. S288c ergos-
terol content was significantly higher during ethanol meta-
bolism as compared to CEN.PK113-7D, but post-ethanol
metabolism CEN.PK113-7D exhibited a significantly higher
ergosterol content (15.9 ± 0.7 mg g-DCW
-1 v. 2.6 ± 0.07
mg g-DCW
-1) as observed during glucose fermentation.
For galactose cultivations, ergosterol content was only
measured during transcriptome sampling, which occurred
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Figure 4 An example of amino acid properties change of CEN. PK113-7D compared to S288c: the gene ERG8 of the ergosterol
synthesis pathway. The gene ERG8 of the ergosterol synthesis pathway contains a total of 4 nonsynonymous SNPs, two of which, located at
nucleotide positions 192 and 75, are analyzed here. The top plots show the CEN.PK Match Frequency, Dominanat AA Frequency, S288c Match
Frequency, and Conversation Distance. The middle plots show the frequency (fraction) of each categorization across the amino acid sequences
resulting from Pfam multi-sequence alignment. The bottom plots shows the characterization of the original S288c amino acid (symbol: blue bar)
and the CEN.PK113-7D amino acid (symbol: red bar). The gene ERG8 contained a total of 4 nonsynonymous SNPs, and Additional file 1, Figure
S5 includes the other 2 nonsynonymous SNPs (nucleotide positions 49 and 247).
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Page 8 of 17Table 3 Physiological characterization of S. cerevisiae strains S288c and CEN.PK113-7D
Strain S288c CEN.PK
113-7D
S288c S288c CEN.PK
113-7D
Substrate Glucose Glucose Galactose Galactose/
Ethanol
Galactose
Mean ±S D
(n = 2)
Mean ±S D
(n = 2)
Mean ±S D
(n = 2)
Mean ±S D
(n = 2)
Mean ±S D
(n = 2)
μ-max (h
-1) 0.31 0.01 0.41 0.01 0.02 0.00 0.14 0.01 0.27 0.00
Carbon Recovery (%) 96.60 1.90 95.50 3.90 n/a n/a n/a n/a 79.60 2.60
Specific Productivity or Consumption Rate
A
-rGluc or -rGal 79.35 5.48 105.15 0.24 1.21 0.57 4.50 0.70 24.28 0.33
rCO2 18.36 0.52 23.62 0.87 0.11 0.01 0.58 0.12 4.31 0.24
rEtOH 37.59 4.39 49.88 0.34 0.01 0.01 -3.97 0.62 3.50 0.26
rAcet 0.24 0.02 1.18 0.04 0.00 0.00 -0.04 0.02 1.10 0.11
rGlyc 6.08 0.94 7.17 2.64 0.00 0.00 -0.58 0.05 0.89 0.09
rPyr 0.47 0.04 0.69 0.06 0.00 0.00 0.00 0.00 0.04 0.01
rSuc 0.01 0.01 0.03 0.05 0.00 0.00 0.00 0.00 0.00 0.00
rX 13.85 1.11 17.79 0.02 0.78 0.05 5.85 0.02 9.49 0.89
-rO2 1.95 0.07 1.98 2.75 0.08 0.01 0.97 0.02 2.91 0.22
Notes: A. (C-mmol g-DCW
-1 h
-1). The term “n/a” refers to not applicable.
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Figure 5 Physiological characterization of S. cerevisiae S288c and CEN.PK113-7D. The plots above show the carbon dioxide evolution rate
and oxygen uptake rate as a function of cultivation time for the strains S288c and CEN.PK113-7D supplemented with glucose and galactose,
respectively. Glucose fermentation (GF), ethanol respiration (ER), galactose respiro-fermentation (GaRF). The black arrow in the S288c Galactose
plot indicates when 10 g L
-1 glucose was supplemented (25 h) when no growth was observed on galactose. The red arrows in all plots indicates
when biomass samples were taken for subsequent transcriptome analysis.
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Page 9 of 17at 78 h for S288c (co-consumption of ethanol and galac-
tose observed), and 35 h for CEN.PK113-7D. The total
ergosterol content on galactose was 6.1 ± 0.04 mg g-DCW
-
1 and 4.6 ± 0.2 mg g-DCW
-1 for CEN.PK113-7D and
S288c, respectively.
Transcriptome Characterization
Differential gene expression between S288c and CEN.
PK113-7D, cultivated on both glucose and galactose,
is summarized in Table 4. The GO characterization (pro-
cess, function, component) for the comparative conditions
S288c v. CEN.PK113-7D cultivated on glucose, and S288c
v. CEN.PK113-7D cultivated on galactose, and divided
into log2- f o l dc h a n g e( l f c )>0a n d<0 ,i sp r e s e n t e di n
Additional file 1 Figure S7 and Figure S8. The metabolic
pathway expression maps for each comparative condition
are included in Additional file 1 Figure S9 and Figure S10.
Lastly, all genes exhibiting statistically significant differen-
tial gene expression (padj < 0.01) and having either a silent
or nonsynonymous SNP are included in Additional file 1
Table S1 and Table S2.
For the condition S288c v. CEN.PK113-7D cultivated
on glucose, the top 272 differentially expressed genes,
ranked according to padj value are characterized into
GO process terms largely dominated by responses to sti-
muli and pheromone, with the dominant metabolic pro-
cess categories being trehalose metabolism, steroid
metabolism, and amino acid transport. Specific genes
consistent with this categorization high in padj value
rank and lfc > 0 are GSY1 (glycogen synthase, lfc 2.0,
padj value rank 23) and for lfc < 0 is HMG1 (HMG-CoA
reductase, lfc -1.7, padj value rank 14). For the condition
S288c v. CEN.PK113-7D cultivated on galactose, the top
501 differentially expressed genes, ranked according to
padj value are characterized into GO process terms
response to simuli and stress, carbohydrate metabolism,
and transport. Specific metabolic genes noteworthy in
this category, high in padj value rank amongst genes
with lfc > 0 include MDH2 (malate dehydrogenase, lfc
2.8, padj value rank 8), FBP1 (fructose-1,6-bisphospha-
tase, lfc 4.2, padj value rank 15), GAD1 (glutamate decar-
boxylase, lfc 3.0, padj value rank 30), GDH3(NADP
+
dependent glutamate dehydrogenase, lfc 3.2, padj value
rank 32),G S Y 1(lfc 1.4, padj value rank 41), and ICL1
(isocitrate lyase, lfc 2.7, padj value rank 54). Similarly,
specific metabolic genes high in padj value rank amongst
genes with lfc < 0 include ARE2 (acyl-coA:sterol acetyl-
transferase, lfc -2.3, padj value rank 10), and CYB5 (cyto-
chrome b5, lfc -1.6, padj value rank 47).
In an effort to further investigate if larger regulatory
mechanisms could be identified the list of genes exhibiting
significant differential expression were submitted to the
Yeast Search for Transcriptional Regulators And Consen-
sus Tracking (YEASTRACT) curated repository of associa-
tions between transcription factors and target genes in S.
cerevisiae [25,26]. The transcription factor, Tec1p, was
identified as directly regulating 21.1% of the total sub-
mitted gene list (See Table 4, 272 genes, S288c glucose v.
CEN.PK113-7D glucose), and was 1.7-fold higher
expressed in CEN.PK113-7D compared to S288c (padj
value = 7.2 × 10
-3). Tec1p was the only identified tran-
scription factor to be significantly differentially expressed,
and strongly regulates FLO11, a flocculin gene required
for invasive growth, and pseudohyphal formation [27].
The transcription factors regulating the highest percentage
of the differentially expressed genes, yet not being differen-
tially expressed themselves, were Sok2p and Ste12p, with
32.5% and 21.5%, respectively, of submitted genes being
directly regulated. Sok2p and Ste12p are transcription fac-
tors negatively regulating pseudohyphal differentiation
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Figure 6 Ergosterol measurements in S. cerevisiae strains S288c
and CEN.PK113-7D. Ergosterol composition (mg g-DCW
-1) was
measured for different samples taken during S288c and CEN.PK113-
7D fermentations, supplemented with glucose and galactose.
Transcriptome sample was taken during the mid-exponential
fermentation phase on glucose or respiration phase on galactose.
For glucose fermentations, early ethanol, mid-ethanol, and stationary
ethanol samples were taken post-diauxic shift to charcterize the
change in ergosterol during growth on ethanol. Error bars are ± SD
(n = 2).
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Page 10 of 17[10]. A similar analysis was performed for galactose; how-
ever, similar results were obtained, with Sok2p and Ste12p
directly regulating 23.1% and 17.4%, respectively, of the
501 differentially expressed genes (See Table 4). The tran-
scription factors differentially expressed themselves were
Msa1p (padj value = 1.37 × 10
-1) and Msa2p (padj value =
1.65 × 10
-1), putative G1-specific cell cycle transcription
activators, and Usv1p, a putative zinc finger transcription
factor regulating growth on non-fermentable carbon
sources. USV1 expression was 2.2-fold higher in CEN.
PK113-7D compared to S288c (padj value = 3.6 × 10
-3).
Although relatively little is known about Usv1p, it has
been shown to be induced post-diauxic shift, consistent
with the deficiency in post-diauxic shift metabolism
observed in S288c [28]. With the exception of Usv1p, all
transcription factors identified are more closely related to
the significant difference in growth rates between strains
rather than their respiro-fermentative metabolism. Meta-
bolic SNPs identified and subsequent analysis did not
identify clear correlations or pathway enrichment that
could explain the lack of respiro-fermentative metabolism
in S288c. Metabolic genes containing nonsynonymous
SNPs in CEN.PK113-7D, significantly differentially
expressed on galactose, and related to oxidative metabo-
lism included ACS1 (Acetyl-CoA synthetase), GAD1 (Glu-
tamate decarboxylase), YAT2 (Carnitine acetyltransferase),
and CCP1 (Mitochondrial cytochrome-c peroxidase)
which were 7.8-fold, 3.2-fold, 4.5-fold, and 2.1-fold higher
in CEN.PK113-7D, respectively (See Additional file 1
Table S2).
Discussion
The physiological characterization clearly suggests that
S288c has a deficiency in metabolism of respiro-fermen-
tative carbon sources, such as ethanol and galactose,
when compared to CEN.PK113-7D. Inspection of the
significantly differentially expressed genes between
strains cultivated on glucose or galactose did not reveal
an obvious gene cluster that would explain this signifi-
cant physiological difference. This is supported both by
the GO characterization and pathway expression
mapping.
There were two central carbon metabolic pathways
enriched with nonsynonymous SNPs that also correlated
with significant differences in phenotype. S. cerevisiae
CEN.PK113-7D exhibited significantly higher ergosterol
content during growth on glucose, and to a lesser extent,
galactose. This is consistent with previous work where
CEN.PK2-1C had very high ergosterol/erg-ester (20.0 mg
g-DCW
-1) and triacylglycerols content (15.2 mg g-DCW
-1)
compared to 9 other S. cerevisiae strains, including FY169
(ergosterol/erg-ester content: 8.5 mg g-DCW
-1; triacylgly-
cerols content: 2.4 mg g-DCW
-1) which is isogenic to
S288c [29,30]. The ergosterol biosynthetic pathway had
significant nonsynonymous SNPs identified in ERG8 and
ERG9, and silent SNPs identified in ERG20 and HMG1.
Both ERG8 and ERG9 were not significantly differentially
expressed, either in glucose or galactose, suggestive again
that phenotypic observations, consistent with genome
sequence variations, are not necessarily directly manifested
at the transcriptome level. Both ERG8 (encodes phosopho-
mevalonate kinase) and ERG9 (encodes squalene synthe-
sase) are essential cytosolic enzymes in the biosynthetic
pathway of isoprenoids and sterols (Δerg8 and Δerg9,w e r e
found to both be auxtrophic for ergosterol in the systema-
tic deletion library), including ergosterol, from mevalonate
[11,31,32]. The ergosterol biosynthetic pathway is highly
regulated through feedback inhibition mechanisms and by
several rate-controlling steps, including that catalyzed by
HMG-CoA reductase, encoded by HMG1 [33,34]. Under
both glucose and galactose, HMG1 expression was signifi-
cantly down-regulated in S288c compared to CEN.PK113-
Table 4 Summary of Differential Gene Expression
Summary of Differential Expression (padj < 0.01) S288c v. CEN.PK113-7D
Glucose (n = 2) Galactose (n =2 )
Total No. of Differentially Expressed Genes 272 501
No. of Genes LFC > 0 204 337
LFC ± SD 2.13 ± 1.41 1.81 ± 1.17
No. of Genes with SNPs Detected 13 17
No. of Genes with Nonsynonymous SNPs 7 10
No. of Genes LFC < 0
LFC ± SD -2.12 ± 1.32 -1.53 ± 1.05
No. of Genes with SNPs Detected 4 4
No. of Genes with Nonsynonymous SNPs 1 0
Notes: Single nucleotide polymorphism (SNP). Standard deviation (SD). Nonsynonymous SNPs defined as a nucleotide modification results in a translated amino
acid modification.
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Page 11 of 177D by 3.2-fold (padj value = 3.3 × 10
-4) and 1.8-fold (padj
value = 8.6 × 10
-3), respectively, correlating with the signif-
icantly less ergosterol content in S288c cultivated on glu-
cose and to a lesser extent, on galactose. Furthermore,
ERG9 has been previously identified as also having a regu-
latory role [35], consistent with the hypothesis that a non-
synonymous SNP resulting in altered protein function
could affect ergosterol synthesis. ERG8 on the other hand
has not been explicitly shown to have a regulatory func-
tion, yet, when the specific activity of 0.06 μmol min
-1 mg
-
1 is compared to other ergosterol synthetic enzymes such
as ERG13 (2.1 in S. cerevisiae), ERG12 (0.77 in S. cerevi-
siae), ERG20 (5.22 in S. cerevisiae), and especially the
known regulator HMG1/HMG2 (0.0035 in S. cerevisiae), it
is suggestive that ERG8 is likely a rate limiting step
[36-44]. There were a large number of nonsynonymous
SNPs that encoded significant changes in amino acid
classes, further suggestive that ERG8 is a strong metabolic
engineering target for understanding the significantly
higher ergosterol content in CEN.PK113-7D. Lastly, the
observation that neither ERG8 nor ERG9 were differen-
tially expressed under glucose or galactose, suggests their
potential affect on phenotype is likely post-translational.
Similar to ergosterol biosynthesis, the galactose uptake
pathway phenotype in S288c was vastly lower rate com-
pared to CEN.PK113-7D, correlating with the nonsy-
nonymous SNP enrichment in GAL1 and GAL10,a n d
silent SNPs in GAL7.N e i t h e rGAL1 (encodes galactoki-
nase) nor GAL10 (encodes UDP-glucose-4-epimerase)
were significantly differentially expressed during growth
on galactose; however, on glucose GAL1 was signifi-
cantly up-regulated (padj value = 9.7 × 10
-4), 2.9-fold in
CEN.PK113-7D. Both Δgal1 and Δgal10 mutants are
unable to grow on galactose as sole carbon sources
[45-47]. The significant number of nonsynonymous
SNPs in both essential galactose genes suggests obvious
targets for explanation of why S288c is incapable of
galactose respiro-fermentative metabolism. Furthermore,
it should be noted that S288c has been described as
Δgal2 (See Additional file 1 Table S3), which may be
ascribed to the presence of 4 SNPs between CEN.
PK113-7D and S288c in the coding region, and 14
SNPs in the upstream region that result in a poor func-
tional Gal2p. However, clearly, S288c is able to co-
metabolize galactose with ethanol and this may be
ascribed by galactose transport by e.g. the hexose
transporters.
A further metabolic engineering benefit of whole
genome sequencing was the detection of a nonsynon-
ymous SNP resulting in a stop codon of PAD1
(encodes phenylacrylic acid decarboxylase). Pad1p is
essential for decarboxylation of aromatic carboxylic
acids conferring resistance to cinnamic acid, and a
nonsynonymous SNP was detected at nucleotide
position 294 (T to G), resulting in a stop codon (TAT
® TAG) [48]. Although Pad1 relevant phenotypes
were not explored, the transcriptome response on glu-
cose revealed significant differential expression of
PAD1 (padj value = 1.5 × 10
-3), with 3.1-fold higher
expression in S288c compared to CEN.PK113-7D. This
is consistent with the stop codon detected in CEN.
PK113-7D at position 294, noting that the total ORF
genomic DNA sequence is 729 nucleotides, and there-
fore unlikely to be transcribed and detected.
Conclusions
Whole high-throughput genome sequencing of S. cerevi-
siae S288c and CEN.PK113-7D resulted in identification
of 13,787 filtered SNPs in CEN.PK113-7D, with a total
of 939 SNPs detected across 158 unique metabolic
genes, 85 of which contained a total of 219 nonsynon-
ymous SNPs. There were two central carbon metabolic
pathways enriched with nonsynonymous SNPs that also
correlated with significant differences in phenotype. S.
cerevisiae CEN.PK113-7D exhibited significantly higher
ergosterol content during growth on glucose, and to a
lesser extent, galactose. The ergosterol biosynthetic
pathway had significant nonsynonymous SNPs identified
in ERG8 and ERG9, and silent SNPs identified in ERG20
and HMG1. The flux through the galactose uptake path-
way was much lower in S288c compared with CEN.
PK113-7D, correlating with the nonsynonymous SNP
enrichment in GAL1 and GAL10, and silent SNPs in
GAL7. More globally, the physiological characterization
clearly suggests that S288c has a deficiency in metabo-
lism of respiratory carbon sources, such as ethanol and
galactose, when compared to CEN.PK113-7D. Inspection
of the significantly differentially expressed genes
between strains cultivated on glucose or galactose did
not reveal an obvious gene cluster that would explain
this significant physiological difference. In summary and
perhaps not surprisingly, transcriptome analysis did not
provide a clear hypothesis for major phenotypes
observed, suggesting that genotype to phenotype corre-
lations are manifested post-transcriptionally or post-
translationally either through protein concentration and/
or function. Clearly, future work must validate these
correlations through genetic engineering of identified
SNPs in either S288c or CEN.PK113-7D to see if desired
phenotypes, such as increased galactose uptake or ergos-
terol synthesis in S288c, are observed. Future work must
also expand on the metabolic SNP analysis presented to
include all 13,787 SNPs, realizing phenotypic observa-
tions may not necessarily be linked directly to metabolic
SNPs, but rather SNPs affecting larger regulatory
mechanisms and networks, such as those governed by
transcription factors. Certainly, as S. cerevisiae continues
to be exploited, particularly for metabolic engineering
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Page 12 of 17applications, the integration of physiological characteri-
zation, transcriptome analysis, and metabolic SNP detec-
tion with high-throughput whole genome sequencing
provides direct correlations between observed pheno-
types and genotypes and offers high probability of suc-
cess metabolic targets.
Methods
Strain Description
S. cerevisiae strain S288c (American Type Culture Col-
lection, ATCC®) and strain CEN.PK113-7D (Scientific
Research and Development, SRD GmbH were used in
this study. Genotype of strain S288c was described by
Mortimer et al, [49], Johnston et al [50], Goffeau et al
[10], Cherry et al [11] and genotype of strain CEN.
PK113-7D was described by Cherry et al [11], van Dij-
ken et al [24]. More information of S. cerevisiae strains
was described in Additional file 1 Table S3.
Genome Sequencing, Annotation and Analysis
DNA Isolation
A standard 500 mL shake flask, supplemented with 10 g
L
-1 glucose and inoculated with a single colony of S. cer-
evisiae S288c or CEN.PK113-7D, was permitted to grow
for 24-48 h at 30°C until visual inspection confirmed a
high optical density. A total of 5 mL culture was ali-
quoted into 15 mL sterile tubes (one per extraction),
centrifuged (4000 RCF) for 5 min, washed with 2 mL
deionized water, and pelleted. Cell pellets were resus-
pended in 0.5 mL lysis buffer. Lysis buffer consisted of
0.1 M Tris pH 8.0, 50 mM EDTA, and 1% SDS final
concentration. The lysis buffer suspension was trans-
ferred to a 1.5 mL FastPrep screw cap tube, to which
200 μL acid-washed glass beads (250-500 μm) and 25
μL 5 M NaCl was added. A FastPrep™ FP120 (QBiogene,
Irwine, CA) was used for cell lysis, with two cycles of 20
s disruption and 1 min on ice. The resulting cell suspen-
sion was centrifuged (13,000 RCF) for 10 min., and the
resulting clear liquid, approximately 350 μL, avoiding
white cell debris and beads, was aspirated with a pipette
and transferred to 1.5 mL microcentrifuge tubes. 400 μL
chloroform (TE-saturated) was added to each tube,
mixed, and a chloroform extraction performed. 1 mL
99% ethanol was added to the resulting suspension,
mixed, centrifuged (13,000 RCF) for 6 min., ethanol dec-
anted, and then resuspended in 70% ethanol. The result-
ing suspension was centrifuged (13,000 RCF) for 6 min.,
ethanol decanted, and pellet permitted to dry for 25-60
min. The pellet was then resuspended in 50 μL2m M
Tris, incubated for 10 min. at 37°C, and stored at -20°C.
Illumina/Solexa Genome Sequencing and SNP Analysis
Isolated DNA from S. cerevisiae S288c and CEN.PK113-
7D were processed to prepare short insert shotgun
libraries at Fasteris SA (Geneva, Switzerland), utilizing
the Solexa technology according to the manufacturer’s
recommendations (Illumina). The whole-genome
sequencing was performed in 2007 on a Genome Analy-
zer “classic” instrument with sequencing kits version 1
and base calling on the Solexa Pipeline (version 0.2.2.5).
SNP detection was performed using two independent
approaches: mapping on the S288c reference sequence
and de novo assembly. The MAQ software package
http://maq.sourceforge.net was used to map the short
base paired-reads (35 bp) to the reference genome
S. cerevisiae S288c version 12.0, available at the Sacchar-
omyces Genome Database (SGD). For consensus calling,
the maq assemble -m command was used to call the
consensus sequences from read mapping. The value
mset to 1 specifies the maximum numbers of mis-
matches allowed for a filtered read. To detect high-qual-
ity SNP identification, the command maq.pl SNPfilter
was set up. The threshold values applied to SNP detec-
tion for the CEN.PK113-7D sequence relative to the
reference sequence were read depth (-d)>5f o rf e w
reads, read depth (-D) < 255 for too many reads,
uniqueness of the region (-w) < 1.5, quality of the read
(-Q) > 50, and best read quality (-n) > 40. These thresh-
old parameter values were tested such that the amount
of coverage and proportion of genome with aligned
sequences was maximized, and a graphical representa-
tion of SNPs was produced to confirm results. The de
novo assembly has been performed using the EDENA
software package http://www.genomic.ch/edena.php as
described previously [21]. The EDENA assembly results
for both whole genome sequencing and for SNP detec-
tion in metabolic genes are presented in Additional file
1, Table S4. The de novo assembly used for SNP detec-
tion was essentially used for an independent verification
of the SNPs detected by mapping on the reference
sequence, as not all the genome was represented. Indeed
a higher coverage, as well as longer insert libraries are
required to achieve more complete de novo assembly.
For purposes of the subsequent SNP analysis only the
MAQ software results were used. The FASTA files of
each genome sequence are available upon request.
All metabolic genes containing SNPs, both silent and
nonsynonymous, were manipulated within the software
BioEdit v7.08 http://www.mbio.ncsu.edu/BioEdit/bioedit.
html. Specifically, the ORF genomics nucleotide
sequence available on Saccharomyces Genome Database
(SGD) http://www.yeastgenome.org were imported into
BioEdit, and the sequences modified with the identified
SNP, creating a new CEN.PK113-7D sequence for that
ORF relative to the original S288c strain. Both the
S288c and CEN.PK113-7D nucleotide sequences were
then translated in fix full frames, and amino acid poly-
morphisms were identified, leading to the categorization
of each SNP as either being silent or nonsynonymous.
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and all relevant amino acid information from UnitProt
were managed in a spreadsheet using Microsoft Excel.
Multi-sequence Pfam alignments were performed using
a custom BioPerl script and the UNIX operating envir-
onment. Calculations and characterization described in
Additional file 1, Figure S3, related to amino acids, were
then performed using Microsoft Excel.
Gene Prediction and Functional Annotation
Genes were predicted in the S. cerevisiae strain CEN.
PK113-7D genome based on the homologies to known
or putative genes in the public database of the S. cerevi-
siae S288c v12.0, sequence available at the Saccharo-
myces Genome Database (SGD). The statistical features
of the genes were predicted by a combination of gene-
finding software. To perform annotation, BLASTN and
GlimmerHMM were applied. GlimmerHMM was used
for prediction the gene structures of strain CEN.PK113-
7D by training the gene models from the strain S288c.
All of the predicted protein-coding genes were anno-
tated by searching against the SGD database using
BLASTP, followed by manual curation.
Development of Genome Browser and SNPs Viewer
The genome browser and SNP viewer were implemen-
ted by PHP source code and MySQL database manage-
ment in our hosting server http://members.dot5hosting.
com/controlpanel/. Currently, our MySQL database
structure contains different features that correspond to
chromosome location, gene position, gene function, GO
process, metabolism, and SNPs.
Fermentation
Medium Formulation
A chemically defined minimal medium of composition
5.0 g L
-1 (NH4)2SO4,3 . 0gL
-1 KH2PO4,0 . 5gL
-1
MgSO4.7H2O, 1.0 mL L
-1 trace metal solution, 300 mg
L
-1 uracil, 0.05 g L
-1 antifoam 204 (Sigma-Aldrich A-
8311), and 1.0 mL L
-1 vitamin solution was used for all
shake flask and 2L well-controlled fermentations [51].
The trace elment solution included 15 g L
-1 EDTA,
0.45 g L
-1 CaCl2.2H2O, 0.45 g L
-1 ZnSO4 .7H2O, 0.3 g L
-1
FeSO4.7H2O, 100 mg L
-1 H3BO4,1gL
-1 MnCl2.2H2O,
0.3 g L
-1 CoCl2.6H2O, 0.3 g L
-1 CuSO4.5H2O, 0.4 g L
-1
NaMoO4.2H2O .T h ep Ho ft h et r a c em e t a ls o l u t i o nw a s
adjusted to 4.0 with 2 M NaOH and heat sterilized.
The vitamin solution included 50 mg L
-1 d-biotin, 200 mg
L
-1 para-amino benzoic acid, 1 g L
-1 nicotinic acid, 1 g L
-1
Ca.pantothenate, 1 g L
-1 pyridoxine HCl, 1 g L
-1 thiamine
HCl, and 25 mg L
-1 m.inositol. The pH of the vitamin
solution was adjusted to 6.5 with 2 M NaOH, sterile-fil-
tered and the solution was stored at 4°C. The final formu-
lated medium, excluding glucose and vitamin solution
supplementation, is adjusted to pH 5.0 with 2 M NaOH
and heat sterilized. For carbon-limited cultivations the
sterilized medium is supplemented with 40 g L
-1 glucose
or 40 g L
-1 galactose, heat sterilized separately, and 1.0 mL
L
-1 vitamin solution is added by sterile filtration (0.20 μm
pore size Ministart®-Plus Sartorius AG, Goettingen,
Germany).
Shake Flask Cultivations and Stirred Tank Fermentations
Shake flask cultivations were completed in 500 mL
Erlenmeyer flasks with two diametrically opposed baffles
and two side-necks with septums for sampling by syr-
inge. Flasks were heat sterilized with 100 mL of med-
ium, inoculated with a single colony, and incubated at
30°C with orbital shaking at 150 RPM. Stirred tank fer-
mentations were completed in well-controlled, aerobic,
2.2L Braun Biotech Biostat B fermentation systems with
a working volume of 2L (Sartorius AG, Goettingen, Ger-
many). The temperature was controlled at 30°C. The
fermenters were outfitted with two disk-turbine impel-
lers rotating at 600 RPM. Dissolved oxygen was moni-
tored with an autoclavable polarographic oxygen
electrode (Mettler-Toledo, Columbus, OH). During
aerobic cultivation the air sparging flow rate was 2 vvm.
The pH was kept constant at 5.0 by automatic addition
of 2 M KOH. Off-gas passed through a condenser to
minimize the evaporation from the fermenter. The fer-
menters were inoculated from shake flask precultures to
an initial OD600 0.01. Two biological replicates were
performed for each fermentation condition.
Off-gas Analysis
The effluent fermentation gas was measured every
30 seconds for determination of O2(g) and CO2(g) con-
centrations by the off-gas analyzer Brüel and Kjær 1308
(Brüel & Kjær, Nærum, Denmark).
Biomass Determination
T h eo p t i c a ld e n s i t y( O D )w a sd e t e r m i n e da t6 0 0n m
using a Shimadzu UV mini 1240 spectrophotometer
(Shidmazu Europe GmbH, Duisberg, Germany). Dupli-
cate samples were diluted with deionized water to
obtain OD600 measurements in the linear range of 0-0.4
OD600 Samples were always maintained at 4°C post-
sampling until OD600 and dry cell weight (DCW) mea-
surements were performed. DCW measurements were
determined through the exponential phase, until station-
ary phase was confirmed according to OD600 and off-gas
analysis. Nitrocellulose filters (0.45 μmS a r t o r i u sA G ,
Goettingen, Germany) were used. The filters were pre-
dried in a microwave oven at 150W for 10 min., and
cooled in a dessicator for 10 min. 5.0 mL of fermenta-
tion broth were filtered, followed by 10 mL DI water.
Filters were then dried in a microwave oven for 20 min.
at 150W, cooled for 15 min. in a desiccator, and the
mass was determined.
Metabolite Concentration Determination
All fermentation samples were immediately filtered
using a 0.45 μm syringe-filter (Sartorius AG, Goettingen,
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Glucose, ethanol, glycerol, acetate, succinate, pyruvate,
fumarate, citrate, oxalate, and malate were determined
by HPLC analysis using an Aminex HPX-87 H ion-
exclusion column (Bio-Rad Laboratories, Hercules, CA).
The column was maintained at 65°C and elution per-
formed using 5 mM H2SO4 a st h em o b i l ep h a s ea ta
flow rate of 0.6 mL min
-1.G l u c o s e ,e t h a n o l ,g l y c e r o l ,
acetate, succinate, citrate, fumarate, malate, oxalate were
detected on a Waters 410 differential refractometer
detector (Shodex, Kawasaki, Japan), and acetate and pyr-
uvate were detected on a Waters 468 absorbance detec-
tor set at 210 nm. Ergosterol measurements were made
according to previous published methods [52].
Transcriptomics
RNA Sampling and Isolation
Samples for RNA isolation from two biological replicates
from the late-exponential phase of glucose-limited and
galactose-limited batch cultivations were taken by
rapidly sampling 25 mL of culture into a 50 mL sterile
Falcon tube with 40 mL of crushed ice in order to
decrease the sample temperature to below 2°C in less
than 10 s. Cells were immediately centrifuged (4000
RCF at 0°C for 2.5 min.), the supernatant discarded, and
the pellet frozen in liquid nitrogen and it was stored at
-80°C until total RNA extraction. Total RNA was
extracted using the FastRNA Pro RED kit (QBiogene,
Carlsbad, USA) according to manufacturer’s instructions
after partially thawing the samples on ice. RNA sample
integrity and quality was determined prior to hybridiza-
tion with an Agilent 2100 Bioanalyzer and RNA 6000
Nano LabChip kit according to the manufacturer’s
instruction (Agilent, Santa Clara, CA).
Probe Preparation and Hybridization to DNA Microarrays
mRNA extraction, cDNA synthesis, labeling, and array
hybridization to Affymetrix Yeast Genome Y2.0 arrays
were performed according to the manufacturer’s recom-
mendations (Affymetrix GeneChip® Expression Analysis
Technical Manual, 2005-2006 Revision 2.0). Washing
and staining of arrays were performed using the Gene-
Chip Fluidics Station 450 and scanning with the Affyme-
trix GeneArray Scanner (Affymetrix, Santa Clara, CA).
Microarray Gene Transcription Analysis
Affymetrix Microarray Suite v5.0 was used to generate
CEL files of the scanned DNA microarrays. These CEL
files were then processed using the statistical language
and environment R v5.3 (R Development Core Team,
2007, http://www.r-project.org), supplemented with Bio-
conductor v2.3 (Biconductor Development Core Team,
2008, http://www.bioconductor.org) packages Biobase,
affy, gcrma, and limma [53]. The probe intensities were
normalized for background using the robust multiarray
average (RMA) method only using perfect match (PM)
probes after the raw image file of the DNA microarray
was visually inspected for acceptable quality. Normaliza-
tion was performed using the qspline method and gene
expression values were calculated from PM probes with
the median polish summary. Statistical analysis was
applied to determine differentially expressed genes using
the limma statistical package. Moderated t-tests between
the sets of experiments were used for pair-wise compar-
isons. Empirical Bayesian statistics were used to moder-
ate the standard errors within each gene and Benjamini-
Hochberg’s method was used to adjust for multi-testing.
A cut-off value of adjusted p < 0.01 was used for statisti-
cal significance [54]. Statistically significant differential
gene expression lists were then submitted to the GO
Term Finder (version 0.83) of the Saccharomyces Gen-
ome Database (SGD) for GO process, function, and
component statistically significant identification (p <
0.01). Furthermore, the same differential gene expres-
sion lists were submitted to the Expression Viewer
(Pathway Tools version 12.0 generated by SRI Interna-
tional on SGD) for metabolic pathway mapping and
identification [11].
Data Deposition
Genome sequence and annotated gene of S. cerevisiae
CEN.PK113-7D were deposited at sysbio database
http://www.sysbio.se/cenpk. Normalized gene expression
data were deposited at the GEO database http://www.
ncbi.nlm.nih.gov/geo/ with accession number GPL2529
(platform), GSM536874-GSM536881 (samples), and
GSE21479 (series).
Additional material
Additional file 1: Additional Files. Figure S1. Title: Gene Ontology
terms for SNP characterization. Description: Gene Ontology (GO) function
and component terms for the nonsynonymous SNPs identified in CEN.
PK113-7D compared to S288c. Figure S2. Title: SNP enrichment in S.
cerevisiae metabolism. Description: The metabolic map, produced using
the Saccharomyces Genome Database (SGD) Expression Viewer (SRI
International Pathway Tools version 12.0, based upon S. cerevisiae S288c,
version 12.0) was created using the SNP data produced for CEN.PK113-
7D compared to S288c. Figure S3. Title: Methodology for SNP
characterization at amino acid level. Description: The flow-diagram
describes the bioinformatics approach taken to estimate the likelihood of
occurrence of a nonsynonymous SNP in CEN.PK113-7D or S288c. Figure
S4. Title: Conservation distance. Description: The Conservation Distance,
previously described in Additional file 1, Figure S3, is plotted for all 210
nonsynonymous SNPs. Figure S5. Title: SNP analysis of ERG8 at
nucleotide positions 49 and 247. Description: The gene ERG8 of the
ergosterol synthesis pathway contains a total of 4 nonsynonymous SNPs,
two of which, located at nucleotide positions 49 and 247, are analyzed.
Figure S6. Title: Amino acid characterization of SNPs detected between
S288c and CEN.PK113-7D. Description: Amino Acid Characterization-CEN.
PK113-7D vs S288c Profiles. Figure S7. Title: Gene Ontology terms for
S288c v. CEN.PK113-7D (Glucose). Description: Gene Ontology (GO)
process, function, and component terms for differentially expressed
genes of S288c vs. CEN.PK113-7D cultivated on glucose. Figure S8. Title:
Gene Ontology terms for S288c vs. CEN.PK113-7D (Galactose).
Description: Gene ontology (GO) process, function, and component
terms for differentially expressed genes of S288c vs. CEN.PK113-7D
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Page 15 of 17cultivated on galactose. Figure S9. Title: Metabolic pathway expression
mapping for S288c Glucose vs. CEN.PK113-7D Glucose. Description: The
metabolic map produced using the Saccharomyces Genome Database
(SGD) Expression Viewer (SRI International Pathway Tools version 12.0,
based upon S. cerevisiae S288c, version 12.0) was created using
statistically significant log2-fold expression values for S288c glucose vs.
CEN.PK113-7D glucose. Figure S10. Title: Metabolic pathway expression
mapping for S288c Galactose vs. CEN.PK113-7D Galactose. Description:
The metabolic map produced using the Saccharomyces Genome
Database (SGD) Expression Viewer (SRI International Pathway Tools
version 12.0, based upon S. cerevisiae S288c, version 12.0) was created
using statistically significant log2-fold expression values for S288c
galactose vs. CEN.PK113-7D galactose. Table S1. Title: Transcriptome-
S288c v CEN.PK113-7D Glucose. Description: List of significant genes
(padj< 0.01). Table S2. Title: Transcriptome-S288c v CEN.PK113-7D
Galactose. Description: List of significant genes (padj < 0.01). Table S3.
Title: Description of S. cerevisiae strains. Table S4. Title: EDENA
determination for de novo assembly of S288c and CEN.PK113-7D
sequences
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